文献速递生殖医学

比较对照生育女性与复发性流产患者围着床期子宫内膜T-bet/GATA3比值:参考范围的建立与应用

Comparing the peri-implantation endometrial T-bet/GATA3 ratio between control fertile women and patients with recurrent miscarriage: establishment and application of a reference range.
PubMed 文献 · Hum Reprod · 2023-01-01

这项回顾性研究在私立生殖中心比较了120例男性不育IVF对照女性与93例复发性流产(RM)患者围着床期中子宫内膜T-bet/GATA3比值,对照参考范围为≤0.22,RM组比值显著更高(P=0.02),19.4%(18/93)的RM患者比值超出参考范围。

要点

  • 对照生育女性围着床期子宫内膜T-bet/GATA3比值参考范围为≤0.22(以第95百分位数定义上限)。
  • RM组子宫内膜T-bet/GATA3比值显著高于对照组(P=0.02)。
  • 19.4%(18/93)的RM患者比值超出参考范围。

核心结论

  • RM患者围着床期子宫内膜T-bet/GATA3比值显著高于对照生育女性。
  • 研究提示异常子宫内膜T-bet/GATA3比值可能是RM的危险因素之一。
  • 需进一步研究按参考范围随访比值正常与异常的RM患者妊娠结局。

研究设计与样本

  • 回顾性研究,在私立生殖中心开展。
  • 对照组为120例因男性不育接受IVF且首个IVF周期后活产的女性。
  • 研究组为93例确诊RM、至少连续两次临床自然流产发生于孕12周前的女性。
  • 子宫内膜样本于IVF治疗或妊娠前月经周期黄体中期采集。
  • 采用免疫组化染色与定量分析计算T-bet+和GATA3+细胞占子宫内膜总细胞的百分比及T-bet/GATA3比值。

主要发现

  • 以第95百分位数定义黄体中期子宫内膜T-bet/GATA3比值上限,对照生育女性参考范围为≤0.22。
  • RM组T-bet/GATA3比值显著高于对照组(P=0.02)。
  • 19.4%(18/93)的RM女性黄体中期T-bet/GATA3比值高于参考范围。

关键数值与推荐

  • 对照生育女性黄体中期子宫内膜T-bet/GATA3比值参考范围:≤0.22(以第95百分位数定义上限)。
  • RM组与对照组T-bet/GATA3比值比较:P=0.02。
  • RM组中比值高于参考范围者占19.4%(18/93)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 所有患者均来自单中心。
  • 子宫内膜T-bet/GATA3比值的稳定性与临床价值需进一步研究。
  • 需进一步研究按参考范围随访比值正常与异常的RM患者妊娠结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Is the ratio of endometrial T-box expressed in T cell (T-bet) and GATA-binding protein 3 (GATA3) changed in patients with recurrent miscarriage (RM) compared to fertile controls? SUMMARY ANSWER: Our study showed a significantly higher T-bet/GATA3 ratio in patients with RM compared with fertile controls. WHAT IS KNOWN ALREADY: The endometrial T-bet (Th1 lineage-committed transcription factor)/GATA3 (Th2 lineage-committed transcription factor) ratio could represent the Th1/Th2 balance, which is particularly important for healthy pregnancy. However, a reliable reference range for the T-bet/GATA3 ratio during the peri-implantation period has not yet been established for use in clinical practice. STUDY DESIGN, SIZE, DURATION: This was a retrospective study carried out in a private fertility center. The control group included 120 women in couples undergoing IVF treatment for male infertility, who had experienced a live-birth baby following the first IVF cycle. The study group included 93 women diagnosed with RM that experienced at least two consecutive clinically spontaneous miscarriages before gestational week 12. The ratio of T-bet/GATA3 was calculated in the control group and RM group. PARTICIPANTS/MATERIALS, SETTING, METHODS: Endometrium samples were collected at mid-luteal phase of the menstrual cycle prior to IVF treatment or pregnancy. The percentage of T-bet+ and GATA3+ cells in total endometrial cells was analyzed using immunohistochemical staining and quantitative analysis. MAIN RESULTS AND THE ROLE OF CHANCE: Using the 95th percentile to define the upper limits of the endometrial T-bet/GATA3 ratio during the mid-luteal phase, the reference range of control fertile women was ≤0.22. Compared with the control group, the RM group exhibited a significantly higher T-bet/GATA3 ratio (P = 0.02), and 19.4% (18/93) women with RM exhibited a T-bet/GATA3 ratio above the reference range in the mid-luteal phase. LIMITATIONS, REASONS FOR CAUTION: All patients were recruited from a single center. The stability and clinical value of the endometrial T-bet/GATA3 ratio require further investigation. WIDER IMPLICATIONS OF THE FINDINGS: The present study suggests that an abnormal endometrial T-bet/GATA3 ratio may be one of the risk factors of RM. Further studies are needed to follow up the pregnancy outcomes in patients with RM with normal and abnormal endometrial T-bet/GATA3 ratio according to the reference range. STUDY FUNDING/COMPETING INTEREST(S): This work was supported by Shenzhen Fundamental Research Program (JCYJ20180228164631121, JCYJ20190813161203606, JCYJ20220530172817039). There are no conflicts of interest to declare. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Yu S, Diao L, Lian R, et al. Comparing the peri-implantation endometrial T-bet/GATA3 ratio between control fertile women and patients with recurrent miscarriage: establishment and application of a reference range. Hum Reprod. 2023. PMID: 37353913. doi:10.1093/humrep/dead132

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。